secwatch.observer — SEC 8-K summary
======================================

Issuer:     Schrodinger, Inc. (SDGR)
CIK:        0001490978
Form:       8-K
Filed at:   2026-06-29T20:29:15+00:00
Accession:  0001490978-26-000059
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Schrödinger receives $57M from Lilly's acquisition of co-founded Ajax Therapeutics
--------------------------------------------------------------------------------

- Received ~$57M cash from Eli Lilly's acquisition of Ajax Therapeutics, a company co-founded by Schrödinger.
- Eligible for additional cash payments upon achievement of specified clinical and regulatory milestones by Ajax.
- Acquisition completed June 29, 2026; Ajax is a biotech company co-founded by Schrödinger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1490978/000149097826000059/0001490978-26-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1490978/000149097826000059/sdgr-20260629.htm
  HTML page:      https://secwatch.observer/filing/0001490978-26-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer